Insider Transactions Reported by 8 Insiders of IGC Pharma, Inc.

Symbol
IGC on NYSE
Location
Potomac, MD

There are no Buy or Sell transactions made by insiders since 25 Dec 2024

IGC Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) 10%+ Owner $4.7M 22 Mar 2024
Ram Mukunda CEO, Director $1.69M 17 Oct 2025
CLAUDIA GRIMALDI PFO, Director $479K 17 Oct 2025
RICHARD K. PRINS Director $362K 17 Oct 2025
James Moran Director $315K 17 Oct 2025
ROHIT GOEL Senior Director of Finance&PAO $79.9K 13 May 2021
John E. LYNCH Director $45.7K 31 May 2022
TERRY L. LIERMAN Director 17 Oct 2025

Recent Insider Transactions by Companies or Individuals for IGC Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.